ApprovalTrail

Approval · Notice of Compliance 19313 · 2017

GRASTEK: Notice of Compliance 19313

Issued May 17, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19313
Date
May 17, 2017
Company
Alk-Abello IncPort Washington, New York, United States
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Transfer of drug identification number

Products in this notice

BrandDINStatus today
GRASTEK02418304Marketed

Medicinal ingredients